The poster, titled“Anti-cancer Activity of (Z)-Endoxifen-Related Compounds in ERα+ Breast Cancer,” explores the optimization of therapeutic efficacy and tolerability through modifications to ...
SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that a poster detailing the anti-cancer activity of (Z ...